Ocugen, Inc. (OCGN)
1.385
+0.04
(+3.36%)
USD |
NASDAQ |
May 27, 16:00
1.40
+0.02
(+1.08%)
After-Hours: 16:47
Ocugen Cash from Investing (Quarterly) : -0.006M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| REGENXBIO, Inc. | 70.59M |
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| Sarepta Therapeutics, Inc. | -134.39M |
| Krystal Biotech, Inc. | -63.58M |
| Gilead Sciences, Inc. | 1.77B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.79M |
| Cash from Financing (Quarterly) | 34.98M |
| Free Cash Flow | -59.58M |
| Free Cash Flow Per Share (Quarterly) | -0.0666 |
| Free Cash Flow to Equity (Quarterly) | -21.95M |
| Free Cash Flow to Firm (Quarterly) | -20.48M |
| Free Cash Flow Yield | -13.92% |